1. Supplementary Table S2
Correlation between pre-operative plasma miR-451 or miR-486 concentrations
and clinicopathologic features in gastric cancer patients N
Mir-451 a P
Mir-486 a
Sex
Male 31
9.03 ( )
0.26 ( )
Female 25
4.16 ( )
0.181
0.25 ( )
0.315
Age (y)
median
　　66　(35-87)　
<60 15
8.88 ( )
0.28 ( )
60≦ 41
6.09 ( )
0.265
0.22 ( )
0.248
Tumor size (cm)
<5 29
9.03 ( )
0.28 ( ) 5≦ 27
5.17 ( )
0.168
0.22 ( )
0.316
Histological type
Well 34
8.53 ( )
0.30 ( )
Poor 22
5.43 ( )
0.276
0.21 ( )
0.321
lymphatic invasion b - 28
9.46 ( )
0.30 ( ) + 24
5.03 ( )
0.039
0.23 ( )
0.318
venous invasion b
8.04 ( )
0.28 ( )
6.09 ( )
0.262
0.26 ( )
0.356
pT stage
m, sm 21
9.89 ( )
0.31( )
Others 35
5.17 ( )
0.100
0.19 ( )
0.127
pN stage
9.96 ( )
0.30 ( )
5.03 ( )
0.053
0.21 ( )
0.234
pTMN stage
Ⅰ+Ⅱ 33
9.03 ( )
0.31 ( )
Ⅲ+Ⅳ 23
3.86 ( )
0.016
0.19 ( )
0.135
recurrence b,c
8.04 ( )
0.32 ( ) 12
7.02 ( )
0.341
0.23 ( )
0.129
residual tumor 47
8.04 ( )
0.31 ( ) 9
2.74 ( )
0.011
0.10 ( )
0.018
a: Median of concentration (amol/μl) (with 25th-75th percentile)
b: 4 cases could not be resected　
c: 5 cases with residual tumor after operation